大洋生物：关于合计持股5%以上股东减持股份的预披露公告

Core Points - The major shareholder, Mr. Wang Xiangao, plans to reduce his stake in the company by selling up to 570,000 shares, which represents 0.68% of the total shares outstanding [2] - The reduction will take place within a three-month period starting from January 12, 2026, excluding any periods where selling is prohibited by regulatory authorities [2] - As of the announcement date, Mr. Wang holds a total of 648,482 shares, accounting for 0.77% of the company's total shares [2]